Top 7 AI QA Tools for Pharma in 2026

Table of contents

    In the pharmaceutical industry, test results become part of quality documentation and must be reproducible during an audit. A complete record includes links to requirements, execution details, change history, approvals and audit evidence. When selecting an AI-powered quality assurance tool for pharma, organisations should therefore consider test automation, traceability, data integrity and compliance with GxP requirements.

    The ranking opens with QATANA, a platform designed for comprehensive test process management. It combines AI capabilities, manual and automated testing, role-based access, audit logs and on-premise deployment. These features address the key needs of pharmaceutical QA teams by accelerating testing, maintaining control over data and supporting complete test documentation.

    QATANA AI-powered software test management tool

    The ranking covers seven solutions addressing different layers of the quality assurance process. Their capabilities include test management and traceability, end-to-end test execution, digital validation, visual testing and device labs. This comparison will help you select a tool suited to a specific system and validation model.

    Top 7 AI QA Tools for Pharma – Comparison at a Glance

    Rank Tool Main category Deployment model Best use case in pharma
    1 QATANA AI-assisted test management On-premise Controlled testing lifecycle, auditability, and manual and Playwright tests managed in one environment
    2 Tricentis Tosca + qTest + Vera Enterprise automation and digital validation Cloud, on-premise or hybrid, depending on the component Large CSV programmes, formal approvals and complex application environments
    3 Opkey Enterprise application automation and continuous validation Cloud or on-premise Veeva, TrackWise, Oracle, SAP, Workday and other frequently updated systems
    4 Leapwork No-code test automation and continuous validation Cloud, on-premise or hybrid Regression testing of business processes across web, desktop, Salesforce, SAP and Oracle systems
    5 Applitools Visual AI and regulated content control Public cloud, private cloud or on-premise Product websites, portals, applications, eIFUs, PDF documents and mandatory safety communications
    6 ACCELQ Full-stack no-code automation Public cloud, private cloud, on-premise or hybrid Omnichannel processes covering web, mobile, API, desktop and enterprise applications
    7 TestGrid CoTester Agentic testing and device infrastructure Cloud, private cloud or on-premise device lab Mobile applications, patient portals and testing on real devices and browsers

    What Makes an AI QA Tool Ready for Pharmaceutical Applications?

    In a regulated environment, test case generation speed is one of several important selection criteria. The tool should support a controlled process in which requirements, risks, test cases, executions, defects and approvals form a consistent chain. Data integrity, decision traceability and the retention of evidence for the required period are equally important.

    Compliance with GxP, EU GMP Annex 11 and 21 CFR Part 11 depends on how the system is used, configured and maintained within a specific organisation. The assessment should cover procedures, roles, data, supplier qualification and risk analysis. AI capabilities can support this process, while computerised system validation confirms that the solution is fit for its intended use.

    We assessed AI-powered QA tools for pharmaceutical applications across six areas:

    1. Fit for pharmaceutical environments: capabilities, documentation and use cases in pharma, biotech, healthcare or life sciences.
    2. Traceability and audit evidence: links between requirements, tests and results, change history, roles, approvals, reports and data exports.
    3. Control over AI: review of AI-generated content, execution predictability, change management and human involvement in decision-making.
    4. Security and deployment: on-premises deployment, private cloud, data residency, communication with the AI model and access control.
    5. Technology coverage: manual, web, mobile, API, desktop, ERP, CRM and legacy application testing, as well as document and device testing.
    6. Operational scalability: integrations with Jira, CI/CD and automation frameworks, reporting, licensing models and the effort required to maintain tests.

    1. QATANA

    QATANA combines AI capabilities with features that are particularly important in regulated QA environments. The platform centralises test cases, executions, defects, reporting, and the results of manual and automated tests. This enables teams to manage the testing process and documentation within a single controlled environment. AI generates draft test cases from tickets and requirements and helps select regression suites based on the scope of a given release. In a pharmaceutical environment, generated proposals should be reviewed by the people responsible for requirements, quality and risk assessment. QATANA supports this operating model because every AI-generated item remains an editable test artefact, while the team retains responsibility for its final assessment and approval.

    QATANA is particularly well suited to pharmaceutical companies that need a central test management system, want to keep data within their own environment and combine manual testing with Playwright automation. During a proof of concept, organisations should verify specific requirements for electronic signatures, retention, artefact versioning and export formats defined in their applicable SOPs.

    QATANA: for pharma: key facts
    Tool provider: Transition Technologies MS (TTMS)
    Website: ttms.com/ai-software-test-management-tool/
    Solution type: AI-assisted test lifecycle management platform
    Key AI capabilities: Draft test case generation, intelligent regression selection, and analysis of ticket data and release information
    Best use case in pharma: Controlled test management for GxP and non-GxP applications, patient and HCP portals, internal systems and successive software releases
    Deployment model: On-premises, with the option to configure integration with the organisation’s selected AI model
    Integrations: Jira, Playwright, AI models and ticketing systems, as well as test artefact import and export
    Pricing: Custom pricing with a scalable multi-user licensing model
    What to verify before selection: Signatures and approvals required by SOPs, retention policies, versioning, evidence package exports and AI model governance rules

    2. Tricentis Tosca, qTest and Vera

    Tricentis combines three complementary solutions: Tosca for test automation, qTest for test management and Vera for digital validation and process approvals. The platform supports more than 160 technologies and enables end-to-end testing of processes spanning ERP and CRM systems, web applications, APIs and data layers. The integration of Tosca, qTest and Vera supports requirements management, electronic signatures, formal approvals and the collection of evidence required for CSV. The solution can operate in the cloud, on-premises or in a hybrid model, with the latest agentic capabilities developed primarily for cloud environments.

    Tricentis for pharma: key facts
    Tool provider: Tricentis
    Website: www.tricentis.com
    Solution type: Ecosystem for enterprise automation, test management and digital validation
    Key AI capabilities: Agentic test creation from natural language, Tosca Copilot, portfolio and results analysis, and model-based test automation
    Best use case in pharma: Large CSV programmes, complex end-to-end processes, formal approvals and organisations using multiple enterprise applications
    Deployment model: Cloud, on-premises or hybrid, depending on the product and required AI capability
    Integrations: Tosca, qTest and Vera within one process, as well as popular enterprise applications, CI/CD pipelines, APIs, user interfaces and data layers
    Pricing: Custom pricing based on the selected products, number of users and execution scale
    What to verify before selection: Required licence scope, availability of AI capabilities in the selected deployment model, data flows and completeness of the validation package

    3. Opkey

    Opkey automates testing for enterprise applications commonly used in life sciences, including Veeva Vault, TrackWise, Oracle, SAP, Salesforce and ServiceNow. Its AI engine analyses the impact of updates, generates test scenarios and automatically repairs tests following interface changes. The platform supports processes spanning multiple systems and provides pre-built libraries of business processes. For GxP applications, it offers IQ, OQ and PQ protocols, electronic signatures, traceability and automated collection of validation evidence. It is particularly well suited to organisations automating the validation of changes in widely used business applications.

    Opkey for pharma: key facts
    Tool provider: Opkey
    Website: www.opkey.com
    Solution type: No-code test automation and continuous validation for enterprise applications
    Key AI capabilities: Change impact analysis, test generation, self-healing, root cause analysis and intelligent regression scope selection
    Best use case in pharma: Validation of updates to Veeva, TrackWise, Oracle, SAP, Workday and Salesforce, as well as processes spanning multiple applications
    Deployment model: Cloud or on-premises, adapted to the customer’s infrastructure
    Integrations: Veeva, TrackWise, Oracle, SAP, Workday, Salesforce, Jira, Azure DevOps, qTest, Jenkins, ServiceNow and GitHub
    Pricing: Custom pricing; demo and test coverage assessment available
    What to verify before selection: Alignment of pre-built tests with the system configuration, validation protocol content, control over self-healing and maintenance costs following updates

    4. Leapwork

    Leapwork enables visual, no-code automation for web, desktop, ERP, CRM and legacy applications. Its AI capabilities support test generation from natural language, requirements analysis and self-healing while maintaining deterministic scenario execution. The platform’s suitability for GxP environments is demonstrated by its implementation at NecstGen, where 110 workflows were automated and 270 functions within laboratory and quality systems were covered by a compliant process. Leapwork supports cloud, on-premises and hybrid deployment. When selecting a deployment model, organisations should verify the availability of AI capabilities, data processing location and the method used to approve changes proposed by the model.

    Leapwork for pharma: key facts
    Tool provider: Leapwork
    Website: www.leapwork.com
    Solution type: No-code test automation and continuous validation platform
    Key AI capabilities: Natural language test creation, self-healing, knowledge building from requirements and documentation, and coverage generation with traceability to source materials
    Best use case in pharma: Regression automation for web and desktop systems, Salesforce, SAP, Oracle and applications used by quality and operational teams
    Deployment model: Cloud, on-premises or hybrid
    Integrations: Playwright, Selenium, Cucumber, GitHub, CI/CD pipelines, test management systems, SAP, Oracle, Salesforce and Microsoft technologies
    Pricing: Annual subscription with custom pricing based on architecture and execution scale
    What to verify before selection: Availability status of AI capabilities, data processing location, human approval mechanisms and the ability to freeze a validated configuration

    5. Applitools

    Applitools uses Visual AI to detect visual defects that conventional functional tests may overlook. It compares websites, application screens and PDF documents against approved baselines, identifying issues such as obscured messages, insufficient contrast and incorrect content placement. In pharma, it helps control risk information, instructions for use, regulatory messages and approved product content across devices, markets and language versions. Version history, screenshots, detected differences and approvals create an evidence set that supports QA and compliance teams. Applitools is particularly effective as a visual validation layer supporting functional testing and CSV processes.

    Applitools for pharma: key facts
    Tool provider: Applitools
    Website: www.applitools.com
    Solution type: Visual AI, visual, functional and cross-browser testing
    Key AI capabilities: Deterministic visual comparison, detection of significant changes, difference grouping, visual element-based self-healing and root cause analysis
    Best use case in pharma: Control of approved content, warnings, eIFUs, PDFs, product portals, patient applications and digital accessibility
    Deployment model: Public cloud, private cloud or on-premises
    Integrations: Playwright, Cypress, Selenium, Appium, more than 50 frameworks, Jira and popular CI/CD tools
    Pricing: Free trial; Starter and Enterprise plans priced individually
    What to verify before selection: Baseline approval rules, retention of screenshots and detected differences, language version support, audit package exports and the scope of accessibility testing

    6. ACCELQ

    ACCELQ is a no-code platform for testing web, mobile, API and desktop applications, as well as enterprise systems. Its AI capabilities support scenario design, change impact analysis, self-healing and automation maintenance. The platform can test processes spanning multiple systems, such as portals, APIs, Salesforce, SAP and Oracle. SaaS, private cloud, on-premises and hybrid deployment models allow organisations to align the architecture with their data processing policies.

    ACCELQ for pharma: key facts
    Tool provider: ACCELQ
    Website: www.accelq.com
    Solution type: Unified no-code platform for test management and full-stack automation
    Key AI capabilities: Scenario generation, process modelling, change impact analysis, self-healing and AI-assisted automation maintenance
    Best use case in pharma: End-to-end processes spanning web, mobile, API, desktop, backend, Salesforce, SAP, Oracle and other enterprise applications
    Deployment model: Public cloud, private cloud, on-premises or hybrid
    Integrations: Jira, Azure DevOps, Jenkins, GitHub, GitLab, TeamCity, Bamboo, Salesforce, SAP, Oracle and Workday
    Pricing: Annual subscription with custom pricing; a 14-day free trial is available
    What to verify before selection: Validation documentation package, signatures and approvals, complete AI data flow, and the cost of private cloud or on-premises deployment

    7. TestGrid CoTester

    TestGrid combines the CoTester agent with a cloud of real devices and browsers and a private device lab. AI generates tests from requirements or an application URL, updates them following interface changes and allows users to approve each scenario before execution. The platform supports web, mobile, API, visual and performance testing, as well as existing Selenium, Appium, Cypress and Playwright test suites. In pharma, it can support the testing of patient portals, therapeutic applications and solutions used in clinical trials on real devices. For on-premises deployments, organisations should note that the AI capabilities require a connection to TestGrid’s hosted infrastructure.

    TestGrid CoTester for pharma: key facts
    Tool provider: TestGrid
    Website: www.testgrid.io
    Solution type: Agentic testing, test management, and cloud or on-premises device lab
    Key AI capabilities: Test generation from requirements, conversational editing, AgentRx self-healing, error summarisation and results analysis
    Best use case in pharma: Mobile and web applications, patient portals, field solutions and testing on real devices and browsers
    Deployment model: Cloud, private cloud or on-premises device lab; AI capabilities may require an outbound connection
    Integrations: Jira, Jenkins, GitHub Actions, GitLab, Azure DevOps, Selenium, Appium, Cypress and Playwright
    Pricing: Starter plan from USD 199 per user per month, based on pricing available in August 2026; Growth and on-premises plans are priced individually
    What to verify before selection: Scope of data sent to the hosted AI service, data residency, log immutability, retention policies and the ability to operate without external connectivity
    AI QA for pharma
    AI-generated image. The people depicted are fictional.

    Before Implementing an AI QA Tool in Pharma: 9 Questions to Ask the Vendor

    Before selecting a tool, conduct a proof of concept under conditions that closely reflect the actual testing process. This allows you to assess test creation and execution speed, documentation completeness and the ability to reconstruct the entire process during an audit.

    Before selecting and implementing an AI QA tool in a pharmaceutical company, ask the vendor the following questions:

      1. Does the platform connect requirements, test cases, test executions and reported defects?
      2. Which activities and changes are recorded in the audit logs?
      3. Can roles and permissions be configured according to the organisation’s procedures?
      4. Can AI-generated test cases be reviewed, edited and approved before use?
      5. Are manual and automated test results available in one consistent view?
      6. How does on-premises deployment work, and how can the platform connect to an AI model selected by the organisation?
      7. Does the platform integrate with the organisation’s existing tools, such as Jira, Playwright and CI/CD pipelines?
    1. Can test data, reports and other artefacts be imported and exported in the required formats and scope?
    2. How do licensing, deployment, integrations, training and ongoing support affect the total cost of the solution?

    Best AI QA Tool for Pharma: Final Recommendation

    The final decision should reflect the intended use, risk assessment and a proof of concept conducted on a representative process. The solution provider also plays an important role, as its experience affects implementation quality, change management and the audit readiness of the testing process.

    TTMS, the provider of QATANA, has worked in the pharmaceutical industry since 2011, involving more than 400 specialists in over 100 projects and services. The company combines QA engineering with expertise in quality management and computerised system validation in line with GAMP 5 and EU GMP Annex 11. These capabilities are supported by the TTMS Integrated Management System, which includes ISO 9001 and ISO 27001. This enables TTMS to support the entire implementation lifecycle, from requirements definition and tool configuration to validation, maintenance and controlled change management.

    Quality Audit Services

    FAQ

    Is a “21 CFR Part 11 compliant” claim sufficient when selecting an AI QA tool for pharma?

    No. Such a claim usually describes the available features or the way the product has been designed, while compliance is assessed for a specific intended use and implementation. The organisation must determine which electronic records and signatures fall within scope, configure roles, permissions, audit trails, retention policies and procedures, and then demonstrate that the system is fit for its intended use. Integrations with Jira, CI/CD pipelines, code repositories and other systems are also important because data flows may extend beyond the QA tool itself. Vendor documentation can facilitate validation, but responsibility remains with the pharmaceutical company. A proof of concept should therefore include the reconstruction of a complete evidence chain from the original requirement to the approved test result.

    How should AI-generated test cases be validated in pharma?

    An AI-generated test case should be treated as a draft requiring expert review. A person familiar with the requirement and its associated risk should verify the preconditions, test data, steps, expected results, negative scenarios and traceability to the source requirement. The system should record the source, model version, generation date, approver and all subsequent changes. Functionality with a greater potential impact on product quality, patient safety or data integrity requires more rigorous review and independent approval. AI performance should be evaluated against a controlled reference set using measures such as coverage completeness, the number of rejected suggestions and errors identified during review. This approach preserves the time-saving benefits of AI while keeping accountability with qualified personnel.

    Are self-healing tests safe in a validated GxP environment?

    They can be used when the mechanism operates in a controlled manner and maintains a complete record of every change. Automatically correcting a technical locator can reduce false failures, provided that the repair does not alter the meaning of a step, the acceptance criterion or the scope of the test. A well-configured system displays the proposed change, its rationale, and the previous and new values, and requires approval for significant modifications. The organisation should define in its SOPs which repairs may be accepted automatically, which require review and when a test must be reapproved. False positives, false negatives and the effects of self-healing engine updates should also be reviewed periodically. Execution repeatability and decision traceability are more important than the number of tests repaired without tester involvement.

    Can production data from pharmaceutical systems be sent to an external AI model?

    The preferred starting point is to use synthetic, anonymised or masked data limited to the minimum required for testing. Sending production data requires a legal basis, information classification assessment, vendor agreement, transfer controls, retention rules, processing location controls and clear policies regarding model training. Patient data, clinical trial information, safety data and confidential product information require particular protection. An on-premises deployment may still rely on a hosted AI service if an agent or interface communicates with an external model. The architecture should therefore show separately where tests are stored, where automation is executed and where AI processing takes place. Access to sensitive data should be granted only after the vendor provides a clear and verifiable description of the complete data flow.

    What should be done after an update to the AI model used by a QA tool?

    A model update should be managed as a controlled change, with the scope of assessment determined by risk. The first step is to identify which functions use the model and whether the update could affect test generation, regression selection, self-healing, defect classification or reporting. A previously approved reference test set should then be executed, and the results compared with those produced by the earlier version. Any differences should be assessed, documented and approved before the updated model is used more broadly. The change record should include the model version, date, scope, assessment results, accepted limitations and the person responsible for the decision. When a vendor updates the model without offering the option to freeze a version, the agreement should define advance notification, a testing window and a rollback procedure. Effective model version control is essential for maintaining the validated state.

    Wiktor Janicki

    We hereby declare that Transition Technologies MS provides IT services on time, with high quality and in accordance with the signed agreement. We recommend TTMS as a trustworthy and reliable provider of Salesforce IT services.

    Read more
    Julien Guillot Schneider Electric

    TTMS has really helped us thorough the years in the field of configuration and management of protection relays with the use of various technologies. I do confirm, that the services provided by TTMS are implemented in a timely manner, in accordance with the agreement and duly.

    Read more

    Ready to take your business to the next level?

    Let’s talk about how TTMS can help.

    TTMC Contact person
    Monika Radomska

    Sales Manager